The intragastric host-mediated assay for the assessment of the formation of direct mutagens in vivo.
The intragastric host-mediated assay (h.m.a.) was devised and carried out with a view to assessing the formation of direct mutagens in the gastrointestinal tract of mammals. The h.m.a. consists in the injection of nitrosable compounds, NaNO2 and cells of the yeast S. pombe, by gavage into the animals' stomachs and in the recovery of the target cells from the faeces for mutation-induction analysis. Methylurea was chosen as a model nitrosable compound, and the effects of nitrosation modulators such as ascorbic acid and thiocyanate were studied. Cimetidine, a drug nitrosable in vitro, was tested with the system. Positive results were obtained only at very large doses and in artificially produced low pH. The new host-mediated assay seems to be efficient in revealing the formation, in vivo, of direct, short-living mutagens.
D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D002927:Cimetidine / Q000009:adverse effects / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism*; D008297:Male; D008782:Methylurea Compounds / Q000378:metabolism; D051379:Mice; D009153:Mutagens / Q000378:metabolism*; D012568:Schizosaccharomyces / Q000378:metabolism; D012977:Sodium Nitrite / Q000378:metabolism; D013861:Thiocyanates / Q000494:pharmacology
D008782:Methylurea Compounds; D009153:Mutagens; D013861:Thiocyanates; D002927:Cimetidine; D012977:Sodium Nitrite; D001205:Ascorbic Acid